Thromb Haemost 1982; 48(02): 125-126
DOI: 10.1055/s-0038-1657239
Original Article
Schattauer GmbH Stuttgart

Effect of Aspirin on Platelet 5-Hydroxytryptamine and Beta-Thromboglobulin Plasma Levels in Patients with Myeloproliferative Diseases

P Viero
The Division of Haematology, Ospedali Riuniti, Bergamo
,
S Cortelazzo
*   The Division of Haematology, Ospedale Generale Regionale, Vicenza, Italy
,
R Bassan
The Division of Haematology, Ospedali Riuniti, Bergamo
,
T Barbui
The Division of Haematology, Ospedali Riuniti, Bergamo
› Author Affiliations
Further Information

Publication History

Received 15 January 1982

Accepted 29 June 1982

Publication Date:
13 July 2018 (online)

Preview

Summary

14 patients with myeloproliferative diseases (MD) showed low 5-hydroxytryptamine (5-HT) platelet content and high beta-thromboglobulin (β-TG) plasma levels.

This pattern could support the view that MD platelets undergo “in vivo“ degranulation.

A single dose of aspirin was unable to induce modification of platelet 5-HT and plasma β-TG, whereas 6 out of 14 patients

No modification of platelet 5-HT was obtained suggesting that the cause of dense bodies deficiency may lie in the production of abnormal platelets and not be related to “in vivo” degranulation.